Brokerages Anticipate Ceridian HCM Holding Inc (NYSE:CDAY) to Announce $0.10 EPS

Equities analysts expect Ceridian HCM Holding Inc (NYSE:CDAY) to report earnings of $0.10 per share for the current quarter, according to Zacks Investment Research. Five analysts have made estimates for Ceridian HCM’s earnings. The lowest EPS estimate is $0.08 and the highest is $0.12. Ceridian HCM posted earnings per share of $0.05 during the same quarter last year, which would suggest a positive year over year growth rate of 100%. The company is expected to issue its next earnings results on Monday, November 4th.

On average, analysts expect that Ceridian HCM will report full-year earnings of $0.50 per share for the current year, with EPS estimates ranging from $0.47 to $0.54. For the next year, analysts expect that the business will post earnings of $0.68 per share, with EPS estimates ranging from $0.62 to $0.81. Zacks Investment Research’s EPS calculations are an average based on a survey of research analysts that follow Ceridian HCM.

Ceridian HCM (NYSE:CDAY) last issued its earnings results on Tuesday, July 30th. The company reported $0.12 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.07 by $0.05. The firm had revenue of $196.30 million for the quarter, compared to analysts’ expectations of $192.29 million. Ceridian HCM had a net margin of 4.19% and a return on equity of 2.34%. The firm’s revenue was up 9.7% compared to the same quarter last year. During the same quarter last year, the company earned ($0.44) earnings per share.

CDAY has been the topic of a number of research analyst reports. Jefferies Financial Group raised shares of Ceridian HCM from a “hold” rating to a “buy” rating and raised their price objective for the stock from $58.00 to $65.00 in a report on Monday, August 19th. Robert W. Baird raised their price objective on shares of Ceridian HCM from $48.00 to $58.00 and gave the stock an “outperform” rating in a report on Wednesday, July 31st. Cantor Fitzgerald initiated coverage on shares of Ceridian HCM in a report on Wednesday, September 11th. They set an “overweight” rating and a $65.00 price objective on the stock. ValuEngine cut shares of Ceridian HCM from a “buy” rating to a “hold” rating in a report on Wednesday, September 4th. Finally, Credit Suisse Group raised their price objective on shares of Ceridian HCM from $45.00 to $52.00 and gave the stock a “neutral” rating in a report on Wednesday, July 31st. Six investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $56.92.

NYSE:CDAY traded up $0.59 during mid-day trading on Thursday, hitting $49.42. The stock had a trading volume of 568,092 shares, compared to its average volume of 805,465. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.40. Ceridian HCM has a twelve month low of $31.39 and a twelve month high of $58.95. The stock has a 50-day simple moving average of $52.63 and a two-hundred day simple moving average of $51.31. The company has a market capitalization of $6.99 billion, a PE ratio of -988.40 and a beta of 1.47.

In other news, Director Thomas H. Lee Advisors, Llc sold 9,500,000 shares of Ceridian HCM stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $49.27, for a total value of $468,065,000.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Ozzie J. Goldschmied sold 63,000 shares of Ceridian HCM stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $53.99, for a total transaction of $3,401,370.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 17,207,412 shares of company stock worth $895,501,643. 26.90% of the stock is owned by corporate insiders.

Several institutional investors have recently made changes to their positions in the company. Price T Rowe Associates Inc. MD increased its holdings in shares of Ceridian HCM by 31.4% in the 2nd quarter. Price T Rowe Associates Inc. MD now owns 13,864,672 shares of the company’s stock valued at $696,007,000 after acquiring an additional 3,312,089 shares during the period. Vanguard Group Inc. increased its holdings in shares of Ceridian HCM by 30.9% in the 2nd quarter. Vanguard Group Inc. now owns 6,487,533 shares of the company’s stock valued at $325,674,000 after acquiring an additional 1,531,004 shares during the period. BlackRock Inc. increased its holdings in shares of Ceridian HCM by 28.6% in the 2nd quarter. BlackRock Inc. now owns 2,913,790 shares of the company’s stock valued at $146,271,000 after acquiring an additional 647,177 shares during the period. Bamco Inc. NY increased its holdings in shares of Ceridian HCM by 8.2% in the 2nd quarter. Bamco Inc. NY now owns 2,562,171 shares of the company’s stock valued at $128,621,000 after acquiring an additional 195,002 shares during the period. Finally, Echo Street Capital Management LLC increased its holdings in shares of Ceridian HCM by 219.8% in the 2nd quarter. Echo Street Capital Management LLC now owns 644,375 shares of the company’s stock valued at $32,348,000 after acquiring an additional 442,859 shares during the period. 81.29% of the stock is currently owned by institutional investors and hedge funds.

About Ceridian HCM

Ceridian HCM Holding Inc operates as a human capital management (HCM) software company in the United States and internationally. The company offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud platform, which offers scalable and straightforward payroll and HR solutions.

Featured Article: Purposes and Functions of the Federal Reserve

Get a free copy of the Zacks research report on Ceridian HCM (CDAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Ceridian HCM (NYSE:CDAY)

Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.